Reducing CNS-Active Medications to Prevent Falls and Injuries in Older Adults

NACompletedINTERVENTIONAL
Enrollment

2,367

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
AgingAccidental Fall
Interventions
BEHAVIORAL

STOP Falls Educational Intervention

This is a pragmatic, cluster-randomized, parallel-group, controlled clinical trial. The unit of randomization is the clinic, to avoid the risk of contamination if healthcare providers within a clinic were randomized (i.e., reducing the potential for intervention providers to communicate with control providers about the intervention and share materials). Eighteen clinics were identified for the trial, of which 9 were randomized to the intervention and 9 to usual care.

Trial Locations (1)

98101

Kaiser Permanente Washington Health Research Institute, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT05689554 - Reducing CNS-Active Medications to Prevent Falls and Injuries in Older Adults | Biotech Hunter | Biotech Hunter